Posted by Michael Wonder on 08 Feb 2021
International regulators working together to enhance collaboration on COVID-19 observational research
8 February 2021 - In a dedicated COVID-19 workshop, convened under the umbrella of the International Coalition of Medicines Regulatory Authorities, medicine regulators from around the world emphasised the importance of international collaboration and sharing expertise and best practices on observational studies of real world data to facilitate regulatory decision-making on COVID-19 treatments and vaccines.
The workshop was co-chaired by Health Canada and EMA and took place on 25 January 2021.
The main findings of the workshop are summarised in a report, which has been published today.
